Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TBPH | Ordinary Shares | Tax liability | -$96.4K | -11K | -0.76% | $8.74 | 1.44M | May 20, 2022 | Direct | F1, F2 |
holding | TBPH | Ordinary Shares | 92.6K | May 20, 2022 | By Trust |
Id | Content |
---|---|
F1 | Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
F2 | Includes 2,313 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2022. |